Recent Headlines
AnaSpec Showcases Fluorescent Nucleic Acid Probes
The detection of nucleic acids is important for many life science research tasks, such as sequencing, cDNA synthesis and cloning, RNA transcription and transfection. Accurate detection of DNA/RNA is key to the success of these techniques. DNA/RNA concentration is often measured by UV absorbance at... - May 19, 2012 - AnaSpec, EGT Group
AnaSpec Offers PEGylated Peptides Synthesis
PEGylation has become a well-accepted method for the delivery of biopharmaceuticals-especially peptide and protein drugs.1-4 Simple modification of a drug with polyethylene glycol (PEG) not only is capable of improving the drug’s solubility, diminishing the potential for aggregation, and... - May 16, 2012 - AnaSpec, EGT Group
Grand Rounds at Metropolitan Hospital - Compounding Options in Medicine: Special Focus on Physiatry
Dr Haldey, PharmD, President of Royal Care Pharmacy, Inc, will provide a comprehensive overview of pharmacy compounding with a specific focus on physiatry. - May 12, 2012 - Royal Care Pharmacy Inc
Royal Care Pharmacy Will Present at the 5th Annual Wound Symposium
Dr Emil Haldey, the Company’s President, has been invited to speak at the 5th Annual Wound Care Symposium sponsored by NY College of Podiatric Medicine and Nassau University Medical Center. Dr Emil Haldey will discuss history, rationale and benefits of pharmacy compounding for the modern podiatry practice. - May 12, 2012 - Royal Care Pharmacy Inc
Mitegen Announces Consolidation and Improvements to MicroLoops™ Product Lines
MicroLoops™ and MicroLoops™ HT product lines merged and improved with Dual thickness technology, providing an economical option in premium crystal mounts. - May 09, 2012 - MiTeGen, LLC
AnaSpec Highlights SensoLyte® 520 Renin Assays for Human, Mouse & Rat Specific
AnaSpec, EGT Group, the provider of the ultra-sensitive SensoLyte® 520 Human Renin Assay Kit also provides renin kits specific for mouse and rat - the SensoLyte® 520 Mouse Renin Assay Kit and SensoLyte® 520 Rat Renin Assay Kit. Using proprietary 5-FAM/QXL™ 520 fluorescence... - May 09, 2012 - AnaSpec, EGT Group
OSO BioPharmaceuticals Invests $5 Million in Aseptic Filling Suite
State-of-the-art line will increase capacity and yield of liquid, suspension and lyophilized products. - May 02, 2012 - OSO BioPharmaceuticals Manufacturing, LLC
Carotech to Share Latest Breakthrough in Tocomin SupraBio Research at SupplySide MarketPlace, New York
They will be sharing with customers and visitors the latest clinical data of their patented and bioenhanced natural full spectrum palm tocotrienol complex. - April 27, 2012 - Carotech Inc.
AnaSpec Introduces Pancreatic β-Cells Specific Antibodies - Anti-hFXYD2γa
AnaSpec, EGT Group is pleased to announce the release of three antibodies (two monoclonal and one polyclonal) against FXYD2γa. FXYD2γa is a regulating subunit of the NA+-K+-ATPase and has been identified as a unique and specific pancreatic beta cell surface biomarker. In individuals... - April 19, 2012 - AnaSpec, EGT Group
RayBiotech, Inc. and Innopsys Announce Co-Marketing Partnership
RayBiotech, Inc. today announced that it has entered into a co-marketing partnership with Innopsys of Carbonne, France to promote the sales of RayBiotech’s G-Series and Quantibody series of antibody arrays and array testing services with Innopsys’ Innoscan laser microarray scanning... - April 13, 2012 - RayBiotech, Inc
U.S. Granted Patent 8,088,385 B2 Strengthens Advanced Cancer Therapeutics’ Anti-Cancer Product Portfolio
Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, today announced that it has been granted U.S. Patent 8,088,385 B2 titled “PFKFB3 inhibitor for the treatment of a Proliferative Cancer” by the United States Patent... - April 04, 2012 - Advanced Cancer Therapeutics
AnaSpec Highlights HiLyte Fluor™ Dyes Collection for Labeling Amine and Thiol-Modified Oligos
AnaSpec is pleased to highlight their wide collection of amine and thiol reactive 6-isomeric dyes of fluoresceins and rhodamines, and AnaSpec’s own proprietary HiLyte Fluor™ dyes for labeling amine and thiol modified oligonucleotides. Fluorescent dye-labeled oligos are widely used as... - March 29, 2012 - AnaSpec, EGT Group
Carotech to Showcase Natural Palm Mixed Carotene (Caromin) & Palm Tocotrienol Complex (Tocomin) at FIC 2012, Shanghai
Carotech will share latest scientific developments and application strategies of its Tocomin and Caromin series of ingredients - March 24, 2012 - Carotech Inc.
AnaSpec Develops AMC Resins for SPPS
Peptide-7-amino-4-methylcoumarin conjugates (peptide-AMCs) are widely used as fluorogenic substrates to study proteases. The preparation of peptide-AMCs usually involves solution phase synthesis since AMC lacks an additional functional group for attachment to a solid support. Although solid-phase... - March 22, 2012 - AnaSpec, EGT Group
MoBiTec GmbH, Germany, Closes Distribution Agreement for Transcreener® HTS System Platform with BellBrooks Labs, USA
BellBrook Labs, USA, is dedicated to providing the pharmaceutical industry with enabling screening tools to accelerate the discovery of more effective therapies. Their proprietary Transcreener® HTS Platform was developed to move more new targets into HTS more rapidly, and to streamline selectivity profiling within a target family. The partnership with MoBiTec, Germany, will enable BBL to offer their excellent products for High-Throughput Screening to scientists in Germany. - March 14, 2012 - MoBiTec GmbH
RRI Group/Akesis Has Been Part of 60 Dermatology Development Programs
Let RRI Group/Akesis put its Clinical Experience to work for you. RRI Group/Akesis' passion is helping Companies...Grow. - March 08, 2012 - RRI Group/Akesis
TransEnterix to Unveil New SPIDER Surgical System Instruments at SAGES
Platform delivers smallest incision in single-site market while replicating triangulation of multi-port systems - March 02, 2012 - TransEnterix
MoBiTec GmbH, Germany, to Exhibit at Annual Conference of the Association for General and Applied Microbiology (VAAM) 2012 in Tuebingen, Germany
Presentation of new High End Imaging Tools and Accessories for Cell Culture and Light and Fluorescence Microscopy, Systems for Safe Collection and Transportation of Parasite Material, and a Comprehensive Compilation Booklet on Cell Viability and Cytotoxicity Assays at German Conference of the Association for General and Applied Microbiology (VAAM) 2012. - March 02, 2012 - MoBiTec GmbH
MoBiTec GmbH, Germany, Offers a New Photoconvertible and Photoactivatible Fluorescent Protein Suitable for High-Resolution Microscopy: mIrisFP
MoBiTec GmbH, Germany, supplier of fluorescent probes, screening kits and imaging ware for cutting-edge fluorescence applications and microscopy, introduces mIrisFP, a photoconvertible and photoactivatible fluorescent protein suitable for High-Resolution microscopy: mIrisFP - February 29, 2012 - MoBiTec GmbH
Mitegen Announces Continued Expansion of Product Lines and Offerings for Crystallographers
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, recently announced numerous expansions to both their patented product portfolio and to their line of distributed products. - February 25, 2012 - MiTeGen, LLC
MoBiTec GmbH, Germany, Launches Sale of High End Imaging Tools and Accessories for Cell Culture and Light and Fluorescence Microscopy
MoBiTec GmbH, Germany, supplier of fluorescent probes and research chemicals, introduces a collection of high end imaging tools for cell based imaging, assays and arrays. The product line includes Imaging Dishes and adequate Stage Frames, Imaging Plates, Imaging Chambers, Slide Tray Plates and Affinity Adhesion Slides. For the design of the products excellent materials, high quality processing and assembly technologies and innovative construction principles were chosen. - February 24, 2012 - MoBiTec GmbH
Mitegen Announces Distribution Agreement with Mexico Diffractia S. de R.L.de C.V.
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed a distribution agreement with Mexico Diffractia S. de R.L.de C.V. of... - February 24, 2012 - MiTeGen, LLC
AnaSpec Offers Symmetric & Asymmetric Dimethylated Arginine in Histone Peptides Collection
AnaSpec, EGT Group offers one of the world’s largest selections of Histone GO® (catalog) peptides. The peptides include sequences containing modified amino acids such as methylated (Me1, Me2 and Me3) Lysine; phosphorylated Threonine (pThr) or Serine (pSer); deiminated Arginine (Cit). - February 23, 2012 - AnaSpec, EGT Group
OsoBio Appoints Marian Meyer Director of Labs
Meyer manages the company’s chemistry and microbiology labs, which are responsible for such quality-control services as materials testing and release, environmental monitoring and analytical methods compliance. - February 23, 2012 - OSO BioPharmaceuticals Manufacturing, LLC
AnaSpec Offers Special Pricing for MOG (1-125) Recombinant Proteins
AnaSpec, EGT the first provider of commercial MOG recombinant proteins is pleased to offer a 50% discount off on MOG (1-125) recombinant proteins through the month of February, 2012 to US and Canadian customers. Please mention code “rMOG50%” when ordering to get the discount. AnaSpec's... - February 16, 2012 - AnaSpec, EGT Group
Milton Boyer Named President of OSO BioPharmaceuticals Manufacturing
Boyer has been responsible for guiding business strategies and creating new growth opportunities at OsoBio since 2008 - February 15, 2012 - OSO BioPharmaceuticals Manufacturing, LLC
AnaSpec Introduces SensoLyte® Factor Xa Activity Assays – Industry’s First Fluorimetric Kits
AnaSpec, EGT Group is pleased to announce the release of the industry first fluorimetric Factor Xa activity assays - The SensoLyte® 520 Factor Xa Assay Kit and the SensoLyte® Rh110 Factor Xa Assay Kit. The SensoLyte® 520 Factor Xa Assay Kit employs a FRET (5-FAM/QXL™ 520)... - February 15, 2012 - AnaSpec, EGT Group
SFL’s Managing Director to Speak at Healthcare Businesswomen’s Association Event
SFL is pleased to announce that Shayesteh Fürst-Ladani, Managing Director of the company, will be speaking at the upcoming Healthcare Businesswomen’s Association European meeting entitled “The Role of Regulatory Affairs in Successful Development and Launch of Healthcare Products” to be held in Basel, Switzerland. - February 09, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
AnaSpec Offers Antibodies Against the Hexa-His and GFP Tags
The introduction of tags, whether short peptides (6X-His, DYKDDDDK, c-myc) or proteins (green fluorescent protein – GFP, glutathione-s-transferase – GST) into recombinant proteins aids in the characterization, localization or purification of the recombinant expressed protein.1-3 As a... - February 03, 2012 - AnaSpec, EGT Group
AnaSpec Highlights Calcein AM for Live Cell Staining
Calcein AM (Calcein acetoxymethyl ester), a non-fluorescent, cell permeable compound, converts to the strongly green fluorescent calcein when hydrolyzed by intracellular esterases in live cells.1-2 It is widely used for determining cell viability since the fluorescence intensity of calcein is... - February 02, 2012 - AnaSpec, EGT Group
AnaSpec Highlights Atrial Natriuretic Peptides in GO® Collection
AnaSpec, EGT Group provides a wide range of GO® (catalog) natriuretic peptides for use in research laboratories. Their selection of atrial natriuretic peptides (ANPs) include the biologically active 1-28 amino acid peptide (human/porcine or rat sequences); shorter ANP fragments; and Biotin, FAM... - February 02, 2012 - AnaSpec, EGT Group
Advanced Cancer Therapeutics Chief Scientific Officer to Present Preclinical Data on Glycolysis Inhibitors at World Cancer Metabolism Summit
Advanced Cancer Therapeutics, LLC (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that Dr. Gilles Tapolsky, ACT’s Chief Scientific Officer, has been selected to present at the World Cancer Metabolism Summit to be held February 1 – February 2, 2012 in Washington, D.C. - February 01, 2012 - Advanced Cancer Therapeutics
Novus Biologicals Added as New Preferred Vendor for the University of Washington
Novus Biologicals is excited to be a preferred vendor for the University of Washington. Novus’ extensive product line will soon be added to the UW online ordering system, and all UW researchers will now receive 5% off any order. Novus Biologicals is committed to developing and maintaining... - January 28, 2012 - Novus Biologicals
AnaSpec Expands SensoLyte® 520 Renin Assay Kits Collection
AnaSpec, the provider of the ultra-sensitive SensoLyte® 520 Human Renin Assay Kit now provides renin kits specific for mouse and rat - the SensoLyte® 520 Mouse Renin Assay Kit and SensoLyte® 520 Rat Renin Assay Kit. Using their proprietary 5-FAM/QXL™ 520 fluorescence resonance... - January 25, 2012 - AnaSpec, EGT Group
AnaSpec Introduces SensoLyte® α-Synuclein ELISA Assay
AnaSpec, EGT Group is pleased to announce the release of an ultrasensitive ELISA assay for quantitatingα-synuclein. The SensoLyte® α-Synuclein Quantitative ELISA Kit (Human/Mouse/Rat) provides a convenient and quantitative assay for determining α-Synuclein amount in cell and... - January 25, 2012 - AnaSpec, EGT Group
AnaSpec Offers Speedy 28-Day Custom Polyclonal Antibody Service
When traditional protocols can take almost 90 days, the wait for high-quality custom polyclonal antibodies can be excruciating. AnaSpec is pleased to introduce the Speedy 28-day custom polyclonal antibody service. Leveraging proven technology from Eurogentec, AnaSpec's parent company, this protocol... - January 25, 2012 - AnaSpec, EGT Group
AnaSpec Includes Ghrelin and Obestatin Peptides in GO® Collection
AnaSpec, EGT Group, a leading provider of integrated proteomic and genomic solutions, offers a wide range of ghrelin and obestatin GO® (catalog) peptides for research use. In 1999, Kojima and his group (1) reported the discovery of a growth hormone secretagogue that is involved in the release... - January 19, 2012 - AnaSpec, EGT Group
AnaSpec Introduces Ultra-Sensitive SensoLyte® NADP/NADPH Assay Kit
AnaSpec, EGT Group, the provider of ultra-sensitive fluorimetric SensoLyte® line of assay kits is pleased to announce the release of the SensoLyte® Fluorimetric NADP/NADPH Assay Kit. This assay is a sensitive fluorimetric assay that detects NADP and NADPH without interfering with NAD/NADH. - January 19, 2012 - AnaSpec, EGT Group
AnaSpec Highlights Its Proprietary HiLyte Fluor™ Dye Collection
AnaSpec, EGT Group’s proprietary HiLyte Fluor™ dyes are a series of excellent fluorescent labeling dyes with fluorescence emissions that span the full visible and near infrared spectrum. The hydrophilic property of most of the HiLyte Fluor™ dyes makes conjugations to protein... - January 17, 2012 - AnaSpec, EGT Group
CrystalGenomics Scores KRW 3 Billion in Strategic Equity Investment from KSLSF, a Life Science Fund Backed by the City of Seoul and the Ministry of Knowledge Economy
CrystalGenomics, Inc. (KOSDAQ: CRYSTAL [083790]), a clinical stage biopharmaceutical company headquartered in Korea, has just announced that it has successfully raised KRW 3 Billion (USD 2.6 Million) in a private placement to the Korea Seoul Life Science Fund (KSLSF). This is the third time within... - January 16, 2012 - CrystalGenomics, Inc.
John Quackenbush to Speak at CHI’s Bioinformatics & Cancerinformatics Conference, February 21-23, San Francisco, CA
Dr. Quackenbush will present in the translating biomarker driven cancer treatments into practice session. - January 12, 2012 - Cambridge Healthtech Institute
SignaBlok Awarded DARPA Contract to Support New Technology to Combat Sepsis
SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to introduce company’s new approach to the prevention and treatment of sepsis (blood poisoning). - January 12, 2012 - SignaBlok, Inc.
Aciont® To Present on VisulexTM Technologies at the 4th Ocular & Drug Discovery Conference
Aciont Inc. announced today that both Kongnara Papangkorn, Research Director and Sarah Abdulla Molokhia, Scientific Research Consultant, will present on Aciont’s Visulex technologies at the Global Technology Community’s 4th Ocular & Drug Discovery Conference, February 27-28, 2012,... - January 12, 2012 - Aciont Inc.
Autoscribe Launches US Operation
The formation of Autoscribe Informatics Inc., a wholly owned subsidiary of Autoscribe Ltd, has been announced. Based in Falmouth, MA, USA, it gives Autoscribe, the developers of Matrix software products, a much stronger presence in the US and Canadian markets. Zumatrix Inc. operated as... - January 12, 2012 - Autoscribe Informatics
CrystalGenomics to Present at J.P. Morgan Healthcare Conference on January 12
CrystalGenomics, Inc. (KOSDAQ: CRYSTAL (083790)), a clinical stage biopharmaceutical company headquartered in Korea, has just announced that Joong Myung Cho, Ph.D., President & CEO, will present an overview of CrystalGenomics’ business strategy and an update on its development pipeline on... - January 11, 2012 - CrystalGenomics, Inc.
Declan Doogan of Amarin to Keynote CHI’s Conference on Phase III Clinical Trials
Amarin’s CMO to lead line-up of thought leaders at Cambridge Healthtech Institute’s executive and scientific forum. - December 26, 2011 - Cambridge Healthtech Institute
AnaSpec Highlights HiLyte Fluor™ Dyes Collection - for Labeling Amine and Thiol-Modified Oligos
AnaSpec is pleased to highlight their wide collection of amine and thiol reactive 6-isomeric dyes of fluoresceins and rhodamines, and AnaSpec’s own proprietary HiLyte Fluor™ dyes for labeling amine and thiol modified oligonucleotides. Fluorescent dye-labeled oligos are widely used as... - December 21, 2011 - AnaSpec, EGT Group
TransEnterix Closes $15M in Equity Financing
Second tranche of Series B to accelerate development and commercialization of new flexible surgical tools - December 18, 2011 - TransEnterix
New Lightning-Link® Rapid Antibody Labeling Kits Now for DyLight™ Dyes
The Lightning-Link® Rapid Antibody kits allow direct antibody labeling reactions to be set up in seconds and used within just 20 minutes. Novus has recently expanded their Lighting-Link® Rapid kits to include the following DyLight™ dyes. Lightning-Link® Rapid DyLight... - December 17, 2011 - Novus Biologicals
Novus New Lab Program - Receive 20% Off for New Labs
Novus Biologicals understands the funding constraints and logistical difficulties of starting a new lab. Therefore, Novus is proud to announce a New Lab Program, offering 20% off Novus purchases for your first 3 months. Additionally, Novus will provide a welcome kit full of useful tools for your... - December 16, 2011 - Novus Biologicals